\-\ Texto\\:\\ \ \(0\)\
\-\ comatose\ \(12\)\
\-\ supportive\\ care\ \(16\)\
\-\ lesions\\ in\\ the\\ upper\\ cord\\,\\ medulla\\,\\ brainstem\\,\\ and\\ basal\\ ganglia\\.\\ \\ the\\ basal\\ ganglionic\\ lesions\\ enhance\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ leigh\\&\\#34\\;s\\ disease\\ \\(subacute\\ necrotizing\\ encephalopathy\\)\\.\ \(0\)\
\-\ cerebral\\ ichemia\ \(0\)\
\-\ demylinating\\ disease\ \(1\)\
\-\ toxic\\ encephalopathy\ \(1\)\
\-\ 16\\ year\\ old\\ male\\ diagnosed\\ with\\ pyruvate\\ dehydrogenase\\ deficiency\\ at\\ age\\ 5\\.\\ \\ presents\\ with\\ respiratory\\ failure\\ and\\ coma\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ encephalopathy\\:\\ 0\\.15972472349359482\ \(0\)\
\-\ ichemia\\:\\ 0\\.1399288638724841\ \(0\)\
\-\ pyruvate\\:\\ 0\\.1399288638724841\ \(0\)\
\-\ basal\\:\\ 0\\.12366785708375787\ \(0\)\
\-\ ganglionic\\:\\ 0\\.11438223034178409\ \(0\)\
\-\ demylinating\\:\\ 0\\.11438223034178409\ \(0\)\
\-\ dehydrogenase\\:\\ 0\\.11438223034178409\ \(0\)\
\-\ leigh\\:\\ 0\\.10505228327984568\ \(0\)\
\-\ comatose\\:\\ 0\\.09086469794616162\ \(0\)\
\-\ medulla\\:\\ 0\\.08948356497807225\ \(0\)\
\-\ coma\\:\\ 0\\.08542113046795796\ \(0\)\
\-\ toxic\\:\\ 0\\.07950564974914569\ \(0\)\
\-\ necrotizing\\:\\ 0\\.07915677821392703\ \(0\)\
\-\ brainstem\\:\\ 0\\.07603439259097379\ \(0\)\
\-\ deficiency\\:\\ 0\\.07318771118373861\ \(0\)\
\-\ lesions\\:\\ 0\\.07262096845536342\ \(0\)\
\-\ subacute\\:\\ 0\\.0695984384940188\ \(0\)\
\-\ ganglia\\:\\ 0\\.06941058995993939\ \(0\)\
\-\ 34\\:\\ 0\\.06731440389623992\ \(0\)\
\-\ enhance\\:\\ 0\\.06560932058479807\ \(0\)\
\-\ 16\\:\\ 0\\.06137711958076714\ \(0\)\
\-\ supportive\\:\\ 0\\.059977235262743955\ \(0\)\
\-\ 5\\.\\:\\ 0\\.05850190014354642\ \(0\)\
\-\ administration\\:\\ 0\\.05631206769687571\ \(0\)\
\-\ respiratory\\:\\ 0\\.05631206769687571\ \(0\)\
\-\ \\#\\:\\ 0\\.05320137490382362\ \(0\)\
\-\ failure\\:\\ 0\\.05313425845764074\ \(0\)\
\-\ cord\\:\\ 0\\.05154244317786351\ \(0\)\
\-\ diagnosed\\:\\ 0\\.04987611359992072\ \(0\)\
\-\ care\\:\\ 0\\.04892344677886908\ \(0\)\
\-\ \\&\\:\\ 0\\.04764107765303859\ \(0\)\
\-\ cerebral\\:\\ 0\\.04699121431371541\ \(0\)\
\-\ disease\\:\\ 0\\.04434087432430807\ \(0\)\
\-\ age\\:\\ 0\\.04128429088165565\ \(0\)\
\-\ s\\:\\ 0\\.03890107408118392\ \(0\)\
\-\ following\\:\\ 0\\.03849647233176426\ \(0\)\
\-\ upper\\:\\ 0\\.03273143659315426\ \(0\)\
\-\ \\;\\:\\ 0\\.032149542673850694\ \(0\)\
\-\ contrast\\:\\ 0\\.03036151883822072\ \(0\)\
\-\ presents\\:\\ 0\\.02770863961123692\ \(0\)\
\-\ male\\:\\ 0\\.02452707202995989\ \(0\)\
\-\ at\\:\\ 0\\.01837719290208941\ \(0\)\
\-\ year\\:\\ 0\\.01517627411544309\ \(0\)\
\-\ old\\:\\ 0\\.01388785074384531\ \(0\)\
\-\ \\,\\:\\ 0\\.012890955500823208\ \(0\)\
\-\ \\(\\:\\ 0\\.011466059146727945\ \(0\)\
\-\ \\)\\:\\ 0\\.011325995112909604\ \(0\)\
\-\ in\\:\\ 0\\.006688844922861189\ \(0\)\
\-\ and\\:\\ 0\\.0057145716105466175\ \(0\)\
\-\ the\\:\\ 0\\.004388866181067486\ \(0\)\
\-\ with\\:\\ 0\\.003714418288567928\ \(0\)\
\-\ \\.\\:\\ 0\\.001690454099873632\ \(0\)\
